CytoMed Therapeutics Ltd (GDTC) stock
GDTCNasdaqPharmaceutical PreparationsFiscal year ends December 31
$0.83+0.05 (+6.00%)
Close on Nov 18, 2026Market cap $9.82MP/E –Yield –
CytoMed Therapeutics revenue
Revenue is the money a company takes in from selling its products and services, before any costs are deducted.
For fiscal 2025 it was 324.39K SGD, up 366.7% from the year before.
Annual revenue
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | 324.39K SGD | +366.7% |
| FY2024 | Dec 31, 2024 | 69.50K SGD | – |
See a number that looks wrong?